Skip to main content

Table 2 Weighted prevalence of HPV and corresponding 95% confidence interval (CI) stratified by sample type

From: Estimation of HPV prevalence in young women in Scotland; monitoring of future vaccine impact

 

Urine

Self-taken swab

LBC

HPV type

Prevalence

95% CI

Prevalence

95% CI

Prevalence

95% CI

Any HPV

32.2%

(27.4, 37.0)%

39.5%

(34.2, 44.9)%

49.4%

(47.2, 51.5)%

HPV 16 or 18

10.0%

(6.8, 13.1)%

16.6%

(12.5, 20.7)%

23.0%

(21.2, 24.8)%

HPV 31 or 33 or 45 or 51

9.3%

(6.4, 12.3)%

13.5%

(9.7, 17.3)%

19.1%

(17.4, 20.8)%

Any high-risk HPV

19.1%

(15.0, 23.1)%

29.1%

(24.1, 34.1)%

41.2%

(39.1, 43.4)%

High-risk excluding HPV 16 or 18

13.2%

(9.8, 16.7)%

20.6%

(16.2, 25.0)%

32.3%

(30.2, 34.3)%

High-risk excluding HPV 16, 18, 31, 33, 45 or 51

8.0%

(5.2, 10.8)%

11.2%

(7.7, 14.7)%

21.5%

(19.7, 23.2)%

  1. PTK samples were weighted by SIMD, specimen type and reminder status. LBC samples were weighted by SIMD.